You are here

Single Dose Lipopolysaccharide (LPS) Study In Healthy Volunteers

Last updated on March 14, 2019

FOR MORE INFORMATION
Study Location
Pfizer Investigational Site
London, , SE1 1YR United Kingdom
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Chronic Obstructive Pulmonary Disease (COPD)
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18-50 years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Male or female (of non-child bearing potential) subjects, aged 18-50 years.

- Subjects whose FEV1 and FVC at screening are both greater than or equal to 80% of
their predicted value for age, race, sex and height.

- Subjects who have normoresponsive airways.

- Subjects who are able to successfully complete screening sputum inductions.

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Subjects who have evidence, on review of pre-study laboratory data and full physical
examination, or history of any clinically significant hematological, renal, endocrine,
gastrointestinal, dermatological, hepatic, psychiatric, neurologic diseases.
Specifically liver function tests and CRP must be within the reference range.

- Subjects with a medical history of asthma symptomatology (ie, wheeze and/or dyspnea at
rest).

- Subjects who have experienced a respiratory tract infection within the previous 4
weeks or any other infection within 1 week of dosing

NCT01314885
Pfizer
Completed
Single Dose Lipopolysaccharide (LPS) Study In Healthy Volunteers

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now